Repligen Opens European Training & Innovation Center in Breda

New facility will provide hands-on customer support and showcase the company's bioprocessing technologies.

Apr. 17, 2026 at 11:52am

Got story updates? Submit your updates here. ›

A high-end, photorealistic studio still-life photograph featuring a collection of Repligen's chromatography columns, filtration devices, and analytical solutions arranged elegantly on a clean, monochromatic background, conceptually representing the company's innovative bioprocessing capabilities.Repligen's new European Training & Innovation Center in Breda showcases the company's diverse portfolio of advanced bioprocessing technologies.Waltham Today

Repligen Corporation, a leading life sciences company focused on bioprocessing technology, has announced the grand opening of its new Repligen Training & Innovation Center (RTIC) at its OPUS® Pre-packed Chromatography Columns manufacturing facility in Breda, the Netherlands. The Breda RTIC is Repligen's third global training and innovation center, joining existing locations in Waltham, Massachusetts and Tokyo, Japan.

Why it matters

The new Breda facility will enable Repligen to provide enhanced pre- and post-sales support to its biopharma and CDMO customers in Europe, while also showcasing the company's growing portfolio of innovative bioprocessing solutions. This investment underscores Repligen's commitment to serving its global customer base and maintaining a strong presence in key international markets.

The details

The Breda RTIC features product exhibits and purpose-built demonstration areas where customers can experience Repligen's full range of bioprocessing technologies, including upstream intensification, downstream processing, and analytical solutions. The center will host workshops and hands-on training for Repligen's technical teams and customers.

  • Repligen announced the grand opening of the Breda RTIC on April 17, 2026.
  • The Breda opening event was held on April 15, 2026.

The players

Repligen Corporation

A global life sciences company that develops and commercializes innovative bioprocessing technologies and systems for the biopharmaceutical industry.

Olivier Loeillot

President and Chief Executive Officer of Repligen.

Got photos? Submit your photos here. ›

What they’re saying

“We are excited to open our third RTIC in Breda. The center provides a site for workshops and hands-on training for our technical teams and customers, while also highlighting our increasingly broad and diversified portfolio and end-to-end bioprocessing capabilities. Alongside recent investments in Asia Pacific and continued investment in the U.S., this opening underscores our commitment to serving customers globally.”

— Olivier Loeillot, President and Chief Executive Officer

What’s next

Repligen plans to continue expanding its global customer support network with additional RTIC locations in the future, further enhancing its ability to provide hands-on training and showcase its growing bioprocessing technology portfolio.

The takeaway

Repligen's investment in the new Breda RTIC demonstrates the company's commitment to serving its international customer base and maintaining a strong presence in key global markets. The facility will enable Repligen to provide enhanced pre- and post-sales support, while also showcasing its innovative bioprocessing solutions to biopharma and CDMO customers.